Clorox Beats, Guidance Cut, Shares Down 6%

Clorox posted Q3 adjusted EPS $1.64 beating consensus $1.55, with revenue $1.67 bn flat YoY and organic sales down 1%.
Full‑year adjusted EPS guidance cut to $5.45‑$5.65, below $5.86 consensus, implying a 5% shortfall and ~6% sales decline forecast.
Gross margin fell 140 basis points to 43.2%, and the company expects full‑year margin to drop another 250‑300 bps.
Shares fell 6% after hours; CEO Linda Rendle said GOJO deal adds 3‑point sales boost but dilutes EPS by 2‑4 cents.